delilah tirzepatide Eli Lilly sues companies selling alternative versions of its weight loss drug 1+GIP — tailored just to you. Lilly's tirzepatide cuts diabetes risk,

Patient harm from compounded weight loss shots According to a civil complaint filed against Empower Pharmacy, a 50-year-old Texan woman spent weeks in the hospital and died in 2024 after using untested compounded semaglutide/cyanocobalamin injections as prescribed by the compounder

It seems expensive for the amount of food youre getting, Stacy Antine notes

These findings point to the consideration of GLP-1RAs as a promising treatment option for neurodegenerative diseases

The most common reasons patients stop GLP-1 therapy: Adverse effects: 52% Medication shortages: 33% Cost: 25% An experienced obesity medicine practice can help you manage those common impediments by adjusting for side effects at each visit, working around shortages, and restructuring costs

Bariatric surgery reduces features of nonalcoholic steatohepatitis in morbidly obese patients